Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon dioxide
Abstract
The present invention provides improved methods for producing a solution containing high molecular weight isolated Streptococcus pneumoniae capsular polysaccharides having phosphodiester linkages between saccharide repeat units. In certain methods, CO 2 is supplied to a fermentation culture of Streptococcus pneumoniae bacterial cells that produce capsular polysaccharide serotypes containing phosphodiester linkages between saccharide repeat units. Exemplary Streptococcus pneumoniae serotypes containing a phosphodiester linkage between saccharide repeat units include serotypes 6A, 6B, 19A, and 19F. Supplying CO 2 to the fermentation culture includes adding bicarbonate ions to the fermentation culture, adding carbonate ions to the fermentation culture, adding mixtures of bicarbonate and carbonate ions to the fermentation culture, and overlaying the fermentation culture with CO 2 .
Claims
exact text as granted — not AI-modified1 . A method for producing a solution containing high molecular weight isolated Streptococcus pneumoniae capsular polysaccharides wherein said polysaccharides comprise phosphodiester linkages between repeat units, the method comprising:
a) preparing a fermentation culture of Streptococcus pneumoniae bacterial cells that produce capsular polysaccharides comprising a phosphodiester linkage between repeat units; b) supplying CO 2 to said fermentation culture; c) lysing the bacterial cells in said fermentation culture; and d) isolating Streptococcus pneumoniae capsular polysaccharides from said fermentation culture;
whereby a solution containing high molecular weight isolated Streptococcus pneumoniae capsular polysaccharides wherein said polysaccharides comprise phosphodiester linkages between repeat units is produced.
2 . The method of claim 1 , wherein said Streptococcus pneumoniae capsular polysaccharides are serotype 19A.
3 . The method of claim 1 , wherein said Streptococcus pneumoniae capsular polysaccharides are serotype 6A.
4 . The method of claim 1 , wherein said Streptococcus pneumoniae capsular polysaccharides are serotype 19F.
5 . The method of claim 1 , wherein said Streptococcus pneumoniae capsular polysaccharides are serotype 6B.
6 . The method of claim 1 , wherein supplying CO 2 to said fermentation culture comprises adding bicarbonate ion (HCO 3 − ) to the fermentation culture.
7 . The method of claim 6 , wherein adding HCO 3 − to the fermentation culture comprises adding NaHCO 3 .
8 . The method of claim 1 , wherein supplying CO 2 to said fermentation culture comprises adding carbonate ion (CO 3 2− ) to the fermentation culture.
9 . The method of claim 8 , wherein adding CO 3 2− to the fermentation culture comprises adding Na 2 CO 3 .
10 . The method of claim 9 , further wherein the pH of said fermentation culture is between 6.0 and 6.6.
11 . The method of claim 1 , wherein supplying CO 2 to said fermentation culture comprises a first addition of NaHCO 3 and a second addition of Na 2 CO 3 .
12 . The method of claim 1 , wherein supplying CO 2 to said fermentation culture comprises overlaying the fermentation culture with CO 2 .
13 . The method of claim 1 , wherein lysing the Streptococcus pneumoniae in said fermentation culture comprises adding sodium deoxycholate to said fermentation culture.
14 . The method of claim 1 , wherein the molecular weight of said isolated Streptococcus pneumoniae capsular polysaccharide is at least 480 kDa.
15 . A solution containing high molecular weight isolated Streptococcus pneumoniae capsular polysaccharides wherein said polysaccharides comprise phosphodiester linkages between repeat units, wherein said solution is produced by the method of claim 1 .Join the waitlist — get patent alerts
Track US2010160622A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.